Anal Kanser
Özet
Anal kanserleri, gastrointestinal sistemin nadir görülen maligniteleri olup anal kanal anatomisinin ve histolojisinin doğru bilinmesi tanı için kritiktir. Bu bölgede en sık skuamöz hücreli karsinom (SCC) görülmekte, bunu adenokarsinom ve malign melanoma izlemektedir. SCC vakalarının yaklaşık %90'ında HPV ve HIV enfeksiyonları temel etiyolojik faktörler olarak öne çıkarken, tanı genellikle dijital rektal muayene ve biyopsi ile konulmaktadır. Tedavide cerrahiden ziyade mitomisin-C ve 5-fluorourasil bazlı kemoradyoterapi standart yaklaşımdır ve erken evrelerde yüksek kür oranları sağlanmaktadır. Adenokarsinomlar ise daha agresif seyretmekte, genellikle fistül veya Crohn hastalığı zemininde gelişmekte ve radikal cerrahi müdahale gerektirmektedir. Nadir görülen malign melanom ve nöroendokrin neoplaziler ise yüksek metastaz potansiyelleri nedeniyle oldukça kötü prognoza sahiptir. Evreleme süreci tümör boyutu ve lenf nodu tutulumuna göre TNM sistemiyle yapılırken, tedavi yanıtının takibinde MRI ve PET-BT gibi görüntüleme yöntemleri hayati rol oynamaktadır. Son yıllarda p16/HPV statüsünün prognostik değeri ve immünoterapi seçenekleri de güncel tedavi protokollerine dahil edilmeye başlanmıştır.
Anal cancers are rare gastrointestinal malignancies where understanding anal anatomy and histology is vital for accurate diagnosis, with squamous cell carcinoma (SCC) being the most common type followed by adenocarcinoma and malignant melanoma. Approximately 90% of SCC cases are linked to HPV and HIV infections, and diagnosis is primarily achieved through digital rectal examination and biopsy. The standard treatment for SCC is mitomycin-C and 5-fluorouracil-based chemoradiotherapy rather than surgery, offering high cure rates in early stages. In contrast, adenocarcinomas are more aggressive, often developing from fistulas or Crohn’s disease, and typically require radical surgical intervention. Rare types like malignant melanoma and neuroendocrine neoplasms carry a very poor prognosis due to their high metastatic potential. Staging is conducted using the TNM system based on tumor size and lymph node involvement, while MRI and PET-CT are essential for monitoring treatment response. Recently, the prognostic significance of p16/HPV status and the use of immunotherapy have emerged as important components of modern treatment protocols.
Referanslar
Islami F, Ferlay J, Lortet-Tieulent J, et al. International trends in anal cancer incidence rates. Int J Epidemiol. 2017;46(3):924–38.
Stewart DB, Gaertner WB, Glasgow SC, et al. The American society of colon and rectal surgeons clinical practice guidelines for anal squamous cell cancers (Revised 2018). Dis Colon Rectum. 2018;61(7):755–74.
Adler, Dougles G., Francis A Farraye JMC (2015). Odze and Goldblum Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. (3th ed., p. 28)
Fenger C, Sternberg SS (1997). Histology for pathologists
Lewin KJ, Riddell RH, Weinstein WM. The anal canal. Gastrointest Pathol its Clin Implic. 1992;2:1318–59.
Henry D. Appelman (2015). Sternberg’s Diagnostic Surgical Pathology. (6th ed., p. 1859–70)
Lam AK, Goldblum JR (2019). Tumours of the anal canal: Introduction. WHO Classif Tumours Dig Syst Tumours, 5th ed, WHO Classif Tumours Editor Board (Ed), Int Agency Res Cancer, (5th ed., p.193-214) Lyon.
Welton ML, Lambert R, Bosman FT (2010). Tumours of the anal canal. WHO Classif tumours Dig Syst. (4th ed., p.185-93) Lyon IARC.
Trombetta LJ, Place RJ. Giant condyloma acuminatum of the anorectum: trends in epidemiology and management. Dis colon rectum. 2001;44(12):1878–86.
Johnson LG, Madeleine MM, Newcomer LM,et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer. 2004;101(2):281–8.
Heino P, Goldman S, Lagerstedt U, et al. Molecular and serological studies of human papillomavirus among patients with anal epidermoid carcinoma. Int J cancer. 1993;53(3):377–81.
Wilkinson JR, Morris EJA, Downing A, et al. The rising incidence of anal cancer in E ngland 1990–2010: a population‐based study. Color Dis. 2014;16(7):O234–9.
Shiels MS, Kreimer AR, Coghill AE, et al. Anal cancer incidence in the United States, 1977–2011: distinct patterns by histology and behavior. Cancer Epidemiol Prev Biomarkers. 2015;24(10):1548–56.
De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta‐analysis. Int J cancer. 2009;124(7):1626–36.
Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004;101(2):270–80.
Méndez-Martínez R, Rivera-Martínez NE, Crabtree-Ramírez B, et al. Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men. BMC Infect Dis. 2014;14(1):1–7.
Rao S, Guren MG, Khan K, et al. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol [Internet]. 2021;32(9):1087–100. Available from: https://doi.org/10.1016/j.annonc.2021.06.015
Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987;317(16):973–7.
Radecki Breitkopf C, Finney Rutten LJ, Findley V, et al. Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population. Cancer Med. 2016;5(11):3346–52.
Goldie SJ, Kuntz KM, Weinstein MC, et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. Jama. 1999;281(19):1822–9.
Wong CS, Tsao MS, Sharma V, et al. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 1999;45(2):309–14.
Muleris M, Salmon R, Girodet J, et al. Recurrent deletions of chromosomes 11q and 3p in anal canal carcinoma. Int J cancer. 1987;39(5):595–8.
Cacheux W, Dangles-Marie V, Rouleau E, et al. Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma. Oncotarget. 2018;9(1):464.
Chung JH, Sanford E, Johnson A, et al. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes. Ann Oncol. 2016;27(7):1336–41.
Glynne-Jones R, Nilsson PJ, Aschele C, et al. Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol. 2014;111(3):330–9.
Morris VK, Salem ME, Nimeiri H, et al. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017;18(4):446–53.
Noffsinger AE (2017). Fenoglio-Preiser’s gastrointestinal pathology. Lippincott Williams & Wilkins; (4th ed. p.3202-99)
Frost DB, Richards PC, Montague ED, et al. Epidermoid cancer of the anorectum. Cancer. 1984;53(6):1285–93.
Abbas A, Yang G, Fakih M. Management of Anal Cancer in 2010-Part 1: Overview, Screening, and Diagnosis. Oncol San Fr. 2010;24(4):364.
Serup-Hansen E, Linnemann D, Skovrider-Ruminski W, et al. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal. J Clin Oncol. 2014;32(17):1812–7.
Gilbert DC, Williams A, Allan K, et al. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy. Radiother Oncol. 2013;109(1):146–51.
Meulendijks D, Tomasoa NB, Dewit L, et al. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53. Br J Cancer. 2015;112(8):1358–66.
Sun G, Dong X, Tang X, et al. The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis. Oncotarget. 2018;9(8):8081.
Sekhar H, Zwahlen M, Trelle S, et al. Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study. Lancet Oncol. 2017;18(10):1348–59.
Thomas M, Bienkowski R, Vandermeer TJ, et al. Malignant transformation in perianal fistulas of Crohn’s disease: a systematic review of literature. J Gastrointest Surg. 2010;14(1):66–73.
Zeiton MA, Knight BC, Khaled YN, et al. Carcinoma arising within an anal gland. Case Reports. 2011;2011:bcr1020103426.
Sierra EM, Saenz EV, Martínez PHM, et al. Mucinous adenocarcinoma associated with fistula in ano: report of a case. Tech Coloproctol. 2006;10(1):51–3.
Herfs M, Roncarati P, Koopmansch B, et al. A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine. Br J Cancer. 2018;118(10):1302–12.
Koulos J, Symmans F, Chumas J, et al. Human papillomavirus detection in adenocarcinoma of the anus. Mod Pathol an Off J United States Can Acad Pathol Inc. 1991;4(1):58–61.
Chang GJ, Gonzalez RJ, Skibber JM, et al. A twenty-year experience with adenocarcinoma of the anal canal. Dis colon rectum. 2009;52(8):1375–80.
Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.
Lukovic J, Kim JJ, Krzyzanowska M, et al. Anal adenocarcinoma: a rare malignancy in need of multidisciplinary management. JCO Oncol Pract. 2020;16(10):635–40.
Alcindor T, Tosikyan A, Vuong T, et al. Small-cell anal carcinoma and AIDS: case report and review of the literature. Int J Colorectal Dis. 2008;23(1):135–6.
Cimino-Mathews A, Sharma R, Illei PB. Detection of human papillomavirus in small cell carcinomas of the anus and rectum. Am J Surg Pathol. 2012;36(7):1087–92.
Voong KR, Rashid A, Crane CH, et al. Chemoradiation for high-grade neuroendocrine carcinoma of the rectum and anal canal. Am J Clin Oncol. 2017;40(6):555–60.
Kim ST, Ha SY, Lee J, et al. The clinicopathologic features and treatment of 607 hindgut neuroendocrine tumor (NET) patients at a single institution. Medicine (Baltimore). 2016;95(19).
Bernick PE, Klimstra DS, Shia J, et al. Neuroendocrine carcinomas of the colon and rectum. Dis colon rectum. 2004;47(2):163–9.
Shia J. An update on tumors of the anal canal. Arch Pathol Lab Med. 2010;134(11):1601–11.
Bolivar JC, Harris JW, Branch W, et al. Melanoma of the anorectal region. Surg Gynecol Obstet. 1982;154(3):337–41.
Cagir B, Whiteford MH, Topham A, et al. Changing epidemiology of anorectal melanoma. Dis colon rectum. 1999;42(9):1203–8.
Morson BC, Volkstädt H. Malignant melanoma of the anal canal. J Clin Pathol. 1963;16(2):126.
Helmke BM, Renner M, Poustka A, et al. DMBT1 expression distinguishes anorectal from cutaneous melanoma. Histopathology. 2009;54(2):233–40.
Satzger I, Küttler U, Völker B, et al. Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy–case report and review of the literature. Dermatology. 2010;220(1):77–81.
Gorden A, Osman I, Gai W, et al. Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer Res. 2003;63(14):3955–7.
Helmke BM, Mollenhauer J, Herold-Mende C, et al. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology. 2004;127(6):1815–20.
Cooper PH, Mills SE, Allen MS. Malignant melanoma of the anus. Dis Colon Rectum. 1982;25(7):693–703.
Weinstock MA. Epidemiology and prognosis of anorectal melanoma. Gastroenterology. 1993;104(1):174–8.
Kanaan Z, Mulhall A, Mahid S, et al. A systematic review of prognosis and therapy of anal malignant melanoma: a plea for more precise reporting of location and thickness. Am Surg. 2012;78(1):28–35.
Ben‐Izhak O, Bar‐Chana M, Sussman L, et al. Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma. Histopathology. 2002;41(6):519–25.
Ueyama T, Hashimoto H, Tsuneyoshi M. Leiomyosarcoma of the Anus. Int J Surg Pathol. 1994;1(4).
Srouji MN, Donaldson MH, Chatten J, et al. Perianal rhabdomyosarcoma in childhood. Cancer. 1976;38(2):1008–12.
Flood HD, Salman AA. Malignant fibrous histiocytoma of the anal canal. Dis colon rectum. 1989;32(3):256–9.
Ioachim HL, Weinstein MA, Robbins RD, et al. Primary anorectal lymphoma. A new manifestation of the acquired immune deficiency syndrome (AIDS). Cancer. 1987;60(7):1449–53.
